1 min de lecture
[Press Release] Effectiveness of XAV19 against SARS-CoV-2 variants
-
-
Auteurcontact@xenothera.com
-
Publié7 avril 2021
Articles récents
[Press Release] XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody.
December 16,2022. # Download our press release (english version) # Télécharger notre...
More[Press Release] XENOTHERA signs a memorandum of understanding with the Vietnamese conglomerate Vingroup
September 9,2021. # Download our press release (english version) # Télécharger notre...
More[Press Release] 20 M€ raised by XENOTHERA to accelerate its development
June 29, 2021. # Download our press release (english version) # Télécharger...
More